A citation-based method for searching scientific literature

Catherine L Bladen, David Salgado, Soledad Monges, Maria E Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J Roy, Teodora Chamova, Velina Guergueltcheva, Sophelia Chan, Lawrence Korngut, Craig Campbell, Yi Dai, Jen Wang, Nina Barišić, Petr Brabec, Jaana Lahdetie, Maggie C Walter, Olivia Schreiber-Katz, Veronika Karcagi, Marta Garami, Venkatarman Viswanathan, Farhad Bayat, Filippo Buccella, En Kimura, Zaïda Koeks, Janneke C van den Bergen, Miriam Rodrigues, Richard Roxburgh, Anna Lusakowska, Anna Kostera-Pruszczyk, Janusz Zimowski, Rosário Santos, Elena Neagu, Svetlana Artemieva, Vedrana Milic Rasic, Dina Vojinovic, Manuel Posada, Clemens Bloetzer, Pierre-Yves Jeannet, Franziska Joncourt, Jordi Díaz-Manera, Eduard Gallardo, A Ayşe Karaduman, Haluk Topaloğlu, Rasha El Sherif, Angela Stringer, Andriy V Shatillo, Ann S Martin, Holly L Peay, Matthew I Bellgard, Jan Kirschner, Kevin M Flanigan, Volker Straub, Kate Bushby, Jan Verschuuren, Annemieke Aartsma-Rus, Christophe Béroud, Hanns Lochmüller. Hum Mutat 2015
Times Cited: 314







List of co-cited articles
1133 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
David J Birnkrant, Katharine Bushby, Carla M Bann, Susan D Apkon, Angela Blackwell, David Brumbaugh, Laura E Case, Paula R Clemens, Stasia Hadjiyannakis, Shree Pandya,[...]. Lancet Neurol 2018
390
26

Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
David J Birnkrant, Katharine Bushby, Carla M Bann, Benjamin A Alman, Susan D Apkon, Angela Blackwell, Laura E Case, Linda Cripe, Stasia Hadjiyannakis, Aaron K Olson,[...]. Lancet Neurol 2018
339
22

Dystrophin and mutations: one gene, several proteins, multiple phenotypes.
Francesco Muntoni, Silvia Torelli, Alessandra Ferlini. Lancet Neurol 2003
607
21

Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.
Kevin M Flanigan, Diane M Dunn, Andrew von Niederhausern, Payam Soltanzadeh, Eduard Gappmaier, Michael T Howard, Jacinda B Sampson, Jerry R Mendell, Cheryl Wall, Wendy M King,[...]. Hum Mutat 2009
198
21

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy.
Diane E Frank, Frederick J Schnell, Cody Akana, Saleh H El-Husayni, Cody A Desjardins, Jennifer Morgan, Jay S Charleston, Valentina Sardone, Joana Domingos, George Dickson,[...]. Neurology 2020
98
20

Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
Leonela Amoasii, John C W Hildyard, Hui Li, Efrain Sanchez-Ortiz, Alex Mireault, Daniel Caballero, Rachel Harron, Thaleia-Rengina Stathopoulou, Claire Massey, John M Shelton,[...]. Science 2018
249
19

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.
Yi-Li Min, Hui Li, Cristina Rodriguez-Caycedo, Alex A Mireault, Jian Huang, John M Shelton, John R McAnally, Leonela Amoasii, Pradeep P A Mammen, Rhonda Bassel-Duby,[...]. Sci Adv 2019
109
19

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.
S Ryder, R M Leadley, N Armstrong, M Westwood, S de Kock, T Butt, M Jain, J Kleijnen. Orphanet J Rare Dis 2017
186
19

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Katharine Bushby, Richard Finkel, David J Birnkrant, Laura E Case, Paula R Clemens, Linda Cripe, Ajay Kaul, Kathi Kinnett, Craig McDonald, Shree Pandya,[...]. Lancet Neurol 2010
18

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.
Annemieke Aartsma-Rus, Judith C T Van Deutekom, Ivo F Fokkema, Gert-Jan B Van Ommen, Johan T Den Dunnen. Muscle Nerve 2006
404
18

Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase.
Sylvie Tuffery-Giraud, Christophe Béroud, France Leturcq, Rabah Ben Yaou, Dalil Hamroun, Laurence Michel-Calemard, Marie-Pierre Moizard, Rafaëlle Bernard, Mireille Cossée, Pierre Boisseau,[...]. Hum Mutat 2009
218
18

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Jerry R Mendell, Nathalie Goemans, Linda P Lowes, Lindsay N Alfano, Katherine Berry, James Shao, Edward M Kaye, Eugenio Mercuri. Ann Neurol 2016
302
18

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
682
17

Evidence-based path to newborn screening for Duchenne muscular dystrophy.
Jerry R Mendell, Chris Shilling, Nancy D Leslie, Kevin M Flanigan, Roula al-Dahhak, Julie Gastier-Foster, Kelley Kneile, Diane M Dunn, Brett Duval, Alexander Aoyagi,[...]. Ann Neurol 2012
466
16


Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
Annemieke Aartsma-Rus, Ivo Fokkema, Jan Verschuuren, Ieke Ginjaar, Judith van Deutekom, Gert-Jan van Ommen, Johan T den Dunnen. Hum Mutat 2009
355
16

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
A P Monaco, C J Bertelson, S Liechti-Gallati, H Moser, L M Kunkel. Genomics 1988
919
16

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
15

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Niclas E Bengtsson, John K Hall, Guy L Odom, Michael P Phelps, Colin R Andrus, R David Hawkins, Stephen D Hauschka, Joel R Chamberlain, Jeffrey S Chamberlain. Nat Commun 2017
211
15

The Dystrophin Complex: Structure, Function, and Implications for Therapy.
Quan Q Gao, Elizabeth M McNally. Compr Physiol 2015
141
15

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.
Leonela Amoasii, Chengzu Long, Hui Li, Alex A Mireault, John M Shelton, Efrain Sanchez-Ortiz, John R McAnally, Samadrita Bhattacharyya, Florian Schmidt, Dirk Grimm,[...]. Sci Transl Med 2017
120
14

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.
Chengzu Long, Leonela Amoasii, Alex A Mireault, John R McAnally, Hui Li, Efrain Sanchez-Ortiz, Samadrita Bhattacharyya, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Science 2016
581
14

Ataluren treatment of patients with nonsense mutation dystrophinopathy.
Katharine Bushby, Richard Finkel, Brenda Wong, Richard Barohn, Craig Campbell, Giacomo P Comi, Anne M Connolly, John W Day, Kevin M Flanigan, Nathalie Goemans,[...]. Muscle Nerve 2014
249
13

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Craig M McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S Finkel, Kevin M Flanigan, Nathalie Goemans, Peter Heydemann, Anna Kaminska, Janbernd Kirschner, Francesco Muntoni,[...]. Lancet 2017
209
13

Eteplirsen for the treatment of Duchenne muscular dystrophy.
Jerry R Mendell, Louise R Rodino-Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda P Lowes, Lindsay Alfano, Ann Maria Gomez, Sarah Lewis, Janaiah Kota,[...]. Ann Neurol 2013
454
13

Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.
Paula R Clemens, Vamshi K Rao, Anne M Connolly, Amy D Harper, Jean K Mah, Edward C Smith, Craig M McDonald, Craig M Zaidman, Lauren P Morgenroth, Hironori Osaki,[...]. JAMA Neurol 2020
61
21

Eteplirsen in the treatment of Duchenne muscular dystrophy.
Kenji Rowel Q Lim, Rika Maruyama, Toshifumi Yokota. Drug Des Devel Ther 2017
200
13

Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.
Christopher E Nelson, Yaoying Wu, Matthew P Gemberling, Matthew L Oliver, Matthew A Waller, Joel D Bohning, Jacqueline N Robinson-Hamm, Karen Bulaklak, Ruth M Castellanos Rivera, Joel H Collier,[...]. Nat Med 2019
169
13

The Pathogenesis and Therapy of Muscular Dystrophies.
Simon Guiraud, Annemieke Aartsma-Rus, Natassia M Vieira, Kay E Davies, Gert-Jan B van Ommen, Louis M Kunkel. Annu Rev Genomics Hum Genet 2015
178
12

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.
Joe W McGreevy, Chady H Hakim, Mark A McIntosh, Dongsheng Duan. Dis Model Mech 2015
250
12


A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.
Jean K Mah, Lawrence Korngut, Jonathan Dykeman, Lundy Day, Tamara Pringsheim, Nathalie Jette. Neuromuscul Disord 2014
236
12

The importance of genetic diagnosis for Duchenne muscular dystrophy.
Annemieke Aartsma-Rus, Ieke B Ginjaar, Kate Bushby. J Med Genet 2016
146
12

Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production.
Jay S Charleston, Frederick J Schnell, Johannes Dworzak, Cas Donoghue, Sarah Lewis, Lei Chen, G David Young, Anthony J Milici, Jon Voss, Uditha DeAlwis,[...]. Neurology 2018
100
12

In vivo gene editing in dystrophic mouse muscle and muscle stem cells.
Mohammadsharif Tabebordbar, Kexian Zhu, Jason K W Cheng, Wei Leong Chew, Jeffrey J Widrick, Winston X Yan, Claire Maesner, Elizabeth Y Wu, Ru Xiao, F Ann Ran,[...]. Science 2016
628
12

Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan.
David J Birnkrant, Katharine Bushby, Carla M Bann, Susan D Apkon, Angela Blackwell, Mary K Colvin, Linda Cripe, Adrienne R Herron, Annie Kennedy, Kathi Kinnett,[...]. Lancet Neurol 2018
144
12

Golodirsen: First Approval.
Young-A Heo. Drugs 2020
77
15

X chromosome-linked muscular dystrophy (mdx) in the mouse.
G Bulfield, W G Siller, P A Wight, K J Moore. Proc Natl Acad Sci U S A 1984
11

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges.
Yusuke Echigoya, Kenji Rowel Q Lim, Akinori Nakamura, Toshifumi Yokota. J Pers Med 2018
35
31

Therapeutic developments for Duchenne muscular dystrophy.
Ingrid E C Verhaart, Annemieke Aartsma-Rus. Nat Rev Neurol 2019
144
11

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.
Jonas Juan-Mateu, Lidia Gonzalez-Quereda, Maria Jose Rodriguez, Manel Baena, Edgard Verdura, Andres Nascimento, Carlos Ortez, Montserrat Baiget, Pia Gallano. PLoS One 2015
69
15

Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
David G Ousterout, Ami M Kabadi, Pratiksha I Thakore, William H Majoros, Timothy E Reddy, Charles A Gersbach. Nat Commun 2015
268
11


Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
Craig M McDonald, Erik K Henricson, Richard T Abresch, Tina Duong, Nanette C Joyce, Fengming Hu, Paula R Clemens, Eric P Hoffman, Avital Cnaan, Heather Gordish-Dressman. Lancet 2018
177
10

The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.
P Sicinski, Y Geng, A S Ryder-Cook, E A Barnard, M G Darlison, P J Barnard. Science 1989
993
10

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial.
Jerry R Mendell, Zarife Sahenk, Kelly Lehman, Carrie Nease, Linda P Lowes, Natalie F Miller, Megan A Iammarino, Lindsay N Alfano, Amanda Nicholl, Samiah Al-Zaidy,[...]. JAMA Neurol 2020
81
12

Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy.
Lindsay N Alfano, Jay S Charleston, Anne M Connolly, Linda Cripe, Cas Donoghue, Robert Dracker, Johannes Dworzak, Helen Eliopoulos, Diane E Frank, Sarah Lewis,[...]. Medicine (Baltimore) 2019
37
27

Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.
Yi-Li Min, Francesco Chemello, Hui Li, Cristina Rodriguez-Caycedo, Efrain Sanchez-Ortiz, Alex A Mireault, John R McAnally, John M Shelton, Yu Zhang, Rhonda Bassel-Duby,[...]. Mol Ther 2020
20
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.